Global Gene Therapy Industry Growth Fueled by Precision Medicine Advancements: Read More: https://www.theinsightpartners.com/reports/gene-therapy-market The Gene Therapy Market size is projected to register a CAGR of 14.50% during 2025–2031.

How Stable Isotope Labeled Compounds Are Transforming Modern Pharmaceutical Research: Read more: https://www.theinsightpartners.com/reports/stable-isotope-labeled-compounds-market North America continues to play a pivotal role in the growth of the stable isotope labeled compounds market, supported by strong pharmaceutical research activities, advanced biotechnology infrastructure, and increasing investments in life sciences innovation. The region remains a major hub for drug development, clinical research, and analytical testing, driving demand for stable isotope labeled compounds across various applications. Growing emphasis on precision medicine, biomarker discovery, and advanced analytical techniques further strengthens the market outlook in North America. According to the Stable Isotope Labeled Compounds Market report, the global market size is projected to grow from US$ 341.67 million in 2025 to US$ 734.68 million by 2034. The market is anticipated to register a CAGR of 8.88% during the forecast period from 2026 to 2034.

Innovations Reshaping the Worldwide Gastric Cancer Therapeutics Industry: Read More: https://www.theinsightpartners.com/reports/stomach-cancer-therapeutics-market The stomach cancer therapeutics market size is projected to reach US$ 14.46 billion by 2034 from US$ 5.32 billion in 2025. The market is expected to register a CAGR of 11.76% during 2026–2034. Stomach Cancer Therapeutics Market Analysis: The global stomach cancer therapeutics market is driven by growing gastric cancer cases, increasing adoption of immunotherapy and targeted treatment, and development in biomarker-based precision medicine. The market expands because of improved diagnostic tools, growing oncology research and development pipelines, and increased public awareness.